95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.44%
Revenue growth under 50% of FSM's 22.37%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-0.52%
Negative gross profit growth while FSM is at 23.23%. Joel Greenblatt would examine cost competitiveness or demand decline.
3.37%
EBIT growth below 50% of FSM's 78.52%. Michael Burry would suspect deeper competitive or cost structure issues.
3.37%
Operating income growth under 50% of FSM's 78.52%. Michael Burry would be concerned about deeper cost or sales issues.
116.27%
Net income growth under 50% of FSM's 3575.94%. Michael Burry would suspect the firm is falling well behind a key competitor.
116.67%
EPS growth under 50% of FSM's 3687.50%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
116.67%
Diluted EPS growth under 50% of FSM's 3687.50%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.06%
Dividend growth of 0.06% while FSM is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-2.98%
Negative OCF growth while FSM is at 44.92%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-154.52%
Negative FCF growth while FSM is at 63.38%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
13.83%
10Y revenue/share CAGR under 50% of FSM's 129.20%. Michael Burry would suspect a lasting competitive disadvantage.
5.51%
5Y revenue/share CAGR under 50% of FSM's 67.73%. Michael Burry would suspect a significant competitive gap or product weakness.
39.64%
3Y revenue/share CAGR under 50% of FSM's 84.61%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-6.33%
Negative 10Y OCF/share CAGR while FSM stands at 188.51%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
9.59%
5Y OCF/share CAGR 1.25-1.5x FSM's 7.74%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
77.68%
3Y OCF/share CAGR 1.25-1.5x FSM's 63.60%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
58.27%
Below 50% of FSM's 431.65%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
2532.91%
5Y net income/share CAGR above 1.5x FSM's 58.30%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
4117.56%
3Y net income/share CAGR above 1.5x FSM's 290.12%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
84.86%
10Y equity/share CAGR at 50-75% of FSM's 122.65%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
24.04%
Below 50% of FSM's 58.56%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
19.25%
3Y equity/share CAGR at 50-75% of FSM's 26.15%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
41.31%
Dividend/share CAGR of 41.31% while FSM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
147.79%
Dividend/share CAGR of 147.79% while FSM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
64.03%
3Y dividend/share CAGR of 64.03% while FSM is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
7.97%
AR growth is negative/stable vs. FSM's 19.95%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
42.63%
Inventory growth well above FSM's 20.31%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
4.12%
Asset growth above 1.5x FSM's 0.99%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.09%
BV/share growth above 1.5x FSM's 1.11%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-6.08%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
16.95%
SG&A declining or stable vs. FSM's 47.16%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.